Renewed calls to fully subsidise methadone treatment GPs and addiction experts fear hidden costs are preventing more people from accessing treatment.
Naloxone: What should GPs know? newsGP speaks with an addiction medicine expert about the ‘EpiPen of overdose’.
Should GPs be able to prescribe buprenorphine without restriction? As Australia battles a spike in opioid-related deaths, research suggests advantages in much greater availability of pharmacotherapy treatment.
New report exposes severity of harm caused by opioid use The AIHW has shed light on the global issue of harm from opioid use, focusing on comparisons between Australia and Canada.
We must tackle stigma around treating opioid-dependent patients: Rural GP A GP has called for doctors in the bush to overcome the common stigma associated with treating people with opioid dependency.
GPs critical of ‘intimidating, unpleasant’ warning letter over opioid prescribing One in five of Australia’s GPs has – or will shortly – received a warning letter over their level of opioid prescribing. Many are not happy.
Government to warn almost 5000 GPs over high rates of opioid prescribing RACGP flags concerns over campaign to reduce opioid overuse.
Pharmacists’ codeine fears overstated, GP says While pharmacists have raised concerns about a shortage of low-dose codeine, Dr Evan Ackermann, a GP with a special interest in drugs of dependence, says the evidence supports up-scheduling.
Age of opioid pharmacotherapy patients increasing, report says The median age of opioid pharmacotherapy patients is increasing, according to a recent Australian Institute of Health and Welfare report.
RACGP recommends options for regulation of schedule 8 prescription opioids The RACGP has made a submission to the Department of Health detailing its proposed options for the regulation of schedule 8 prescription opioid medicines.